Packages (Simulation)
Quality Guarantee
Certificate
OVA Conjugated Complement Component 9 (C9)
- Product No.CPB823Mi21
- Organism Species Same name, Different species.
- SourceProtein Conjugation
- Original Molecular Mass63000.0DA
- Buffer FormulationPBS, pH7.4.
- Traits Freeze-dried powder
- Purity> 90%
- Isoelectric Pointn/a
-
Applications
Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein. - Downloadn/a
- UOM 10µg50µg 200µg 1mg 5mg
- FOB
US$
US$
US$
US$
US$
For more details, please contact local distributors!
FORMULA
USAGE
Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
INCREMENT SERVICES
| Magazine | Citations |
| Mainz | Identifizierung neuer potentieller Biomarker für das Kolonkarzinom sowie dessen Vorstufen Info:Source |
| Scientific Reports | Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice pubmed:27444648 |
| FASEB Journal | Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia Pubmed:29279353 |
| Catalog No. | Related products for research use of Organism species | Applications (RESEARCH USE ONLY!) |
| CPB823Mi21 | OVA Conjugated Complement Component 9 (C9) | Immunogen; SDS-PAGE; WB. |